drugset / Trial / NCT04112160
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
RandomizedSingle-groupQuadruple-blindPrevention
Summary
This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
Timeline
- Start
- 2018-06-28
- Primary completion
- 2019-06-30
- Completion
- 2019-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketorolac | Other / unclassified | 30 mg | Intramuscular |